Evidence map›Paper›PMID 11050174›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2000

Endogenously expressed estrogen receptor and coactivator AIB1 interact in MCF-7 human breast cancer cells.

M K Tikkanen, D J Carter, A M Harris, H M Le, D O Azorsa, P S Meltzer, F E Murdoch

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. SRC-3, a Steroid Receptor Coactivator: Implication in Cancer.International journal of molecular sciences · 2021
    Review
  3. Point-activated ESR1Genes & development · 2020
    Article
  4. Article
  5. Article
  6. Differential recruitment of co-regulatory proteins to the human estrogen receptor 1 in response to xenoestrogens.Comparative biochemistry and physiology. Part D, Genomics & proteomics · 2016
    Article
  7. Article
  8. Article
  9. Review
  10. Characterization of transcriptional regulatory domains of ankyrin repeat cofactor-1.Biochemical and biophysical research communications · 2007
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

M K TikkanenThe Hospital of Loimaa, 32201 Loimaa, Finland.
D J Carter
A M Harris
H M Le
D O Azorsa
P S Meltzer
F E Murdoch
Cancer Genetics (United States) · USNational Human Genome Research Institute · USHuman Genome Sciences (United States) · USNational Institutes of Health · US

Funding

ALLOSTERIC REGULATION OF THE ESTROGEN RECEPTOR BY DNAR29DK050028 · NIDDK · UNIVERSITY OF WISCONSIN MADISON · PI MURDOCH, FERN E · 1995 to 1999
–
NIDDK NIH HHS DK50028
6 · The paper itself

Abstract

Coactivators are believed to mediate estrogen-induced gene responses via interaction with estrogen receptors (ER). Currently, a major challenge is to determine the importance of each coactivator in a specific cell type and promoter context in response to a particular ligand. The potential of ER to interact with a growing list of coactivators has been shown in a variety of in vitro and gene transfer assays, yet very few data have demonstrated the interaction of endogenous coactivators with ER in intact cells. We report here a ligand-specific interaction of endogenous human ER (hER) and the AIB1 coactivator in MCF-7 human breast cancer cells by using immunoprecipitation analyses. Complexes between endogenously expressed hER and AIB1 were detected in estradiol-treated cells and to a much lesser extent in cells treated with the partial agonist, monohydroxytamoxifen. We were unable to detect an hER-SRC-1 complex in our immunoprecipitations from MCF-7 cells. The in vitro-binding affinity for mouse ER interaction with AIB1 was estimated to be 40-120 nM. We conclude that AIB1 is a major coactivator for hER in MCF-7 human breast cancer cells.

Indexed as

AnimalsBlotting, WesternBreast NeoplasmsEstradiolFemaleGene ExpressionHistone AcetyltransferasesHumansMiceNuclear Receptor Coactivator 1Nuclear Receptor Coactivator 3Precipitin TestsReceptors, EstrogenReceptors, SteroidSelective Estrogen Receptor ModulatorsTamoxifenEstradiolHistone AcetyltransferasesNCOA1 protein, humanNcoa1 protein, mouseNuclear Receptor Coactivator 1Nuclear Receptor Coactivator 3Receptors, EstrogenReceptors, SteroidSelective Estrogen Receptor ModulatorsTamoxifenTranscription Factors

Identifiers

PMID11050174
PMCPMC18799
OpenAlexW1976439844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.